Peptides 101
An honest, beginner-first guide to peptides: what they are, how they work, and how to use them safely. Drawn from the same verified knowledge base behind every profile on this site. Newest articles first.
A direct comparison of Decapeptide-12 and Palmitoyl Dipeptide-6 on evidence, cost, irritation and fit, so you know whether one product covers you.
Read it →How much vendor quality matters for Pinealon, what the evidence does and does not support, and the checks to run before you buy.
Read it →A direct comparison of NAD+ and 5-Amino-1MQ on evidence quality, cost, side-effect load and fit, so you can decide whether you need one or both.
Read it →A direct comparison of Bronchogen and Cartalax on evidence quality, cost per cycle, side-effect load, and who each one suits.
Read it →What the trials say about tirzepatide and sleep, the likely reasons people report worse sleep after month one, and what to adjust first.
Read it →A direct comparison of Bronchogen and Chonluten on evidence, cost, side-effect load and who each one suits, with a clear view on whether to run them together.
Read it →A direct comparison of Cardiogen and Ovagen on evidence quality, cost, side-effect load and who each one suits, with a clear answer on whether to run both.
Read it →A direct bronchogen vs cardiogen comparison on evidence quality, cost, side-effect load and who each peptide suits, so you can decide if you need one or both.
Read it →A direct comparison of Vesugen and Cartalax on evidence quality, cost, side-effect load and who each one suits.
Read it →A side-by-side look at Vesilute and Bronchogen on evidence, cost, side effects and who each one suits, so you can decide whether one is enough.
Read it →A direct comparison of Vesilute and Prostamax on evidence quality, cost, side-effect load and who each one suits, so you can decide which one fits.
Read it →A side-by-side look at Vesugen and Chonluten on evidence quality, cost, side-effect load and who each one suits, so you can pick one or skip both.
Read it →A look at whether Vesugen and Bronchogen serve different enough organ systems to justify running both, based on what the human and animal evidence actually supports.
Read it →A side-by-side look at the evidence quality, cost, side effects and use case for Vesugen versus Prostamax, two Khavinson-family peptides that are not actually interchangeable.
Read it →A side-by-side look at Vilon and Cardiogen's evidence, cost, and side-effect load to help you decide which one, if either, belongs in your protocol.
Read it →A community thread asked whether Glutathione, NAD+, and Sermorelin can be injected together, and this breaks down what actually pairs well and why.
Read it →A side-by-side look at Vilon's real human data against Ovagen's near-empty evidence base, and what that means for anyone considering the pair.
Read it →A side-by-side look at the evidence, cost, and side-effect profile behind Vilon and Chonluten, and who each one actually fits.
Read it →A look at whether Vilon and Cartalax overlap enough that running both is redundant, or whether they cover separate ground.
Read it →A side-by-side look at Cortagen and Cardiogen covering what evidence actually exists, dosing conventions, side-effect load, and who each peptide realistically suits.
Read it →A side-by-side look at why Vilon has a real evidence trail and Vesilute barely has a profile, and what that means for anyone choosing between them.
Read it →A side-by-side look at Livagen and Cartalax on evidence quality, cost, side effects, and who each one actually fits.
Read it →A practical answer to the r/Peptides question on adding TB-500 to a BPC-157 protocol: dosing, timing, and what each peptide is actually doing.
Read it →A side-by-side on evidence quality, cost, side effects, and who each Khavinson peptide actually suits, so you stop guessing between them.
Read it →A side-by-side look at Livagen and Bronchogen's evidence, dosing, and who each one actually fits.
Read it →A side-by-side look at what Testagen and Cartalax actually have behind them, and why the answer depends on what you're trying to fix.
Read it →A plain look at what Livagen and Prostamax actually have behind them, so you can decide if pairing the two makes sense for your goals or just doubles the guesswork.
Read it →A comparison of Testagen and Vilon on evidence quality, cost, side-effect load, and who each one actually suits, based on what's published rather than what's marketed.
Read it →A side-by-side on livagen vs vesugen looks at the evidence gap, cost, side-effect load, and which one actually fits a given goal.
Read it →A side-by-side look at Livagen and Vilon's evidence quality, cost, and side-effect load to help you decide whether your stack needs one, the other, or neither.
Read it →A side-by-side look at Testagen and Cardiogen's evidence quality, cost, side-effect load, and who each one realistically suits.
Read it →A close read of what Testagen and Bronchogen actually have evidence for, and why stacking them together doesn't make sense for most people.
Read it →A side-by-side look at Testagen and Livagen shows both rest on the same thin, off-target evidence base, so the real question is fit, not a clear winner.
Read it →A side-by-side on evidence quality, cost, side effects, and who actually needs Cortagen, Vilon, or both from the Khavinson bioregulator family.
Read it →A side-by-side look at what Testagen and Prostamax evidence actually supports, what each costs in risk, and who each one realistically fits.
Read it →A side-by-side look at Testagen and Vesugen's evidence, cost, and side-effect load to help you decide whether stacking the two Khavinson peptides makes sense for you.
Read it →A breakdown of why heart rate changes show up on tirzepatide, which patterns are routine and which need a call to your prescriber.
Read it →A side-by-side look at why Thymagen has a thin but real evidence trail and Cardiogen's human-study claims don't hold up.
Read it →A breakdown of what oral NADH, NR, NMN, and injectable NAD+ studies actually used, and the real-world protocol most people run.
Read it →A clear-eyed look at whether SS-31's mitochondrial mechanism actually translates to endurance gains, and what evidence exists versus what is still assumed.
Read it →A look at whether stacking Thymagen and Bronchogen makes sense given how thin and mismatched the evidence behind each one actually is.
Read it →What actually changes how well Ipamorelin works: when you eat, when you inject, and what you eat before bed.
Read it →A clear-eyed look at what SS-31's human trials actually measured for fatigue and energy, versus what the marketing implies.
Read it →A side-by-side look at why Thymalin's decades of Russian cohort data and Cardiogen's near-empty evidence file lead to very different recommendations.
Read it →A side-by-side look at what Thymalin and Bronchogen actually have behind them, so you know which one fits your goal instead of guessing from a vendor listing.
Read it →A walk through using the OHM dosing calculator with real numbers for BPC-157, semaglutide, and retatrutide so you're not guessing at units.
Read it →A practical walkthrough of when subcutaneous injection is enough for peptides like BPC-157 and semaglutide, and the rare cases where route actually matters.
Read it →A look at whether GHK-Cu adds anything real when you layer it with a retinoid, and what the collagen and elastic-fiber evidence actually supports.
Read it →A look at what the GHK and GHK-Cu evidence actually supports for pigmentation, and where it does not.
Read it →A side-by-side look at Thymagen and Vesugen's evidence quality, side-effect load, and cost, so you can tell which one actually matches your goal.
Read it →A side-by-side look at why Thymalin has decades of Russian cohort data behind it while Vesilute has none, and what that means for who should actually run either one.
Read it →A breakdown of PT-141 dosing, from the FDA label to the lower community protocol most people actually run and why the gap between them exists.
Read it →A practical walkthrough of choosing between 0.3, 0.5 and 1 mL insulin syringes so your peptide dose lands on the right line every time.
Read it →A step-by-step way to work out peptide reconstitution math in your head, using round bac water numbers and the syringe markings you already have.
Read it →A look at what the actual GHK research supports for fine lines and where the marketing outruns the data.
Read it →A breakdown of why Thymalin and Ovagen sit on opposite ends of the evidence spectrum, and who actually has a reason to run either one.
Read it →A side-by-side look at Thymalin and Vesugen across human evidence, cost, side effects, and which reader each one actually fits.
Read it →What actually moves the needle on tesamorelin beyond the injection itself: when you eat, when you sleep, and what's on the plate at dinner.
Read it →A look at what the MOTS-c insulin sensitivity data actually shows, separating the strong animal case from the thinner human evidence.
Read it →A look at what human and animal evidence actually says about ipamorelin's effect on IGF-1, and what a realistic IGF-1 response looks like on a real protocol.
Read it →A side-by-side look at Thymagen and Vilon covering evidence quality, cost, side effects, and which one fits which goal.
Read it →A side-by-side look at Thymalin's real human data against Pancragen's total absence of published studies, and why stacking them rarely makes sense.
Read it →A side-by-side look at Thymalin and Vilon on evidence depth, cost, side-effect load, and which reader each one actually suits.
Read it →Semaglutide can lower libido indirectly through weight loss, testosterone shifts, and recovery-related factors, and the fix usually isn't stopping the drug.
Read it →A plain look at what actually supports Vilon results: protein intake, sleep, and why the peptide alone won't do the work of a missing foundation.
Read it →A first-timer's shopping list for a BPC-157, semaglutide, or retatrutide order, covering reconstitution supplies, syringes, storage, and what to skip.
Read it →A side-by-side look at Thymagen and Testagen on evidence, cost, side effects, and which one actually fits a given goal.
Read it →A look at what ipamorelin does to sleep architecture through its GH-pulse mechanism, and where the human evidence for that claim actually stands.
Read it →A breakdown of why Thymalin's evidence base only supports the injectable route, and why oral versions of this peptide skip the science entirely.
Read it →A look at what Thymalin's Russian cohort trials actually measured in the heart, the immune system and COVID recovery, and where that evidence still falls short of a Western RCT.
Read it →A side-by-side look at the evidence, cost, side-effect load, and use case for Nonapeptide-1 and Rigin, so you know which topical actually fits your skin goal.
Read it →A side-by-side look at the actual trial data, cost, and side-effect load behind two popular topical peptides, and which reader each one fits.
Read it →A side-by-side look at Pentapeptide-18 and AHK-Cu on evidence quality, cost, side effects, and which one actually fits your goal.
Read it →A step-by-step storage protocol for BPC-157, semaglutide, and retatrutide that keeps a $100+ vial usable instead of degraded.
Read it →A side-by-side look at Thymagen and Livagen across evidence quality, cost, side effects, and who each one actually fits.
Read it →A side-by-side look at why Thymalin carries real human cohort data while Livagen has none, and what that gap should mean for your stack.
Read it →A side-by-side look at why Thymalin has real human cohort data behind it while Testagen has none for the testosterone claim it's sold on.
Read it →What selank sleep disruption reports actually mean, why the calming peptide rarely causes it, and how semax timing changes the picture.
Read it →A look at why pentapeptide-18 stays a topical cosmetic peptide, what its human and lab data actually show, and why injectable delivery isn't the missing upgrade people assume it is.
Read it →A look at what the KPV evidence base actually shows for gut lining repair and IBD, and where the animal data stops and the human gap starts.
Read it →A side-by-side on evidence quality, cost, side effects, and who each topical peptide actually suits.
Read it →A side-by-side look at the evidence, cost, and side-effect profile for Nonapeptide-1 versus Palmitoyl Dipeptide-6, and which skin goal each one actually fits.
Read it →A breakdown of how the tesamorelin trial protocols compare to the 5-on/2-off community cycle, and what actually determines when to take a break.
Read it →A practical walkthrough of why low dose naltrexone disrupts sleep during titration and the adjustments that actually fix it.
Read it →A look at what Semaglutide's trial data shows for heart, kidney and liver outcomes, not just the scale number.
Read it →A side-by-side on Pentapeptide-18 and Pal-GHK covering the actual human evidence, cost, side-effect load, and which skin goal each one is built for.
Read it →A breakdown of why Epithalon and Thymalin are dosed in short cycles rather than daily, and how long those cycles should actually run.
Read it →A community question about skewed deep sleep on DSIP, answered with what the human trials actually found about DSIP and sleep disruption.
Read it →A look at what the semaglutide trials actually measured for lean mass loss, and what you need to do to keep the loss mostly fat.
Read it →A look at why weight loss on semaglutide stalls and what the trial and clinical-practice data say about pushing past a plateau.
Read it →A breakdown of why oral KPV can cause constipation or bloating early on, what it usually means, and when to change course.
Read it →A look at what the human NAD+ trials actually measured for endurance and walking capacity, versus what the marketing implies.
Read it →A look at what the human trial data actually shows about tesamorelin raising IGF-1, and what that IGF-1 rise translates to in practice.
Read it →A look at whether stacking Pentapeptide-18 and Tripeptide-29 in a topical routine is worth it given how differently their evidence bases stand up.
Read it →A side-by-side on evidence quality, cost, and who each of these two topical peptides actually suits, so you can decide if your serum needs both or just one.
Read it →A look at whether vitamin D, boron, and zinc actually change how PT-141 works, and what the real evidence supports versus what the supplement aisle is selling you.
Read it →A clear-eyed look at what tesamorelin's actual trial data says about sleep, growth hormone pulses, and where the marketing gets ahead of the evidence.
Read it →A clear look at whether thymosin alpha-1 helps tendon and ligament healing directly, or whether it supports recovery from the immune side while other peptides do the structural repair work.
Read it →A side-by-side look at Syn-Ake and Decapeptide-12 across evidence quality, cost, side effects, and which skin concern each one is actually built to solve.
Read it →A look at why ipamorelin injection sites itch, sting, or ache, and when that reaction actually means something is wrong.
Read it →A practical walkthrough of stacking sermorelin with a GLP-1 like tirzepatide, timing it correctly, and what actually happens to weight loss.
Read it →What to take with cagrilintide to protect muscle, gut function, and hydration while the amylin pathway shuts down your appetite.
Read it →A clear-eyed look at what Vilon's Russian human cohorts and in-vitro chromatin studies actually support, and where the evidence still runs thin.
Read it →A side-by-side look at Syn-Ake vs Pentapeptide-18 on evidence quality, cost, and who each topical relaxer peptide actually fits.
Read it →A side-by-side look at what SNAP-8 and Decapeptide-12 actually have behind them, and which one fits which skin concern.
Read it →A side-by-side look at Matrixyl vs Pal-GHK on evidence quality, cost, side effects, and who each one actually fits, using the real studies behind both.
Read it →A close read of the actual evidence behind pairing Pentapeptide-18 with retinol, including why the one human study doesn't isolate the peptide's own effect.
Read it →A side-by-side look at what Matrixyl and Nonapeptide-1 each do, what the evidence actually shows, and which one fits your skin goal.
Read it →A side-by-side look at what Matrixyl and Decapeptide-12 actually treat, what the human data supports, and when running both in one routine makes sense.
Read it →A community question about whether SubQ NAD+ needs to be cycled, answered with the actual protocol people run and what the evidence does and doesn't support.
Read it →A community-sourced breakdown of how much GHK-Cu people actually run, why zinc belongs in the conversation, and how to cut the injection sting.
Read it →A look at whether Nonapeptide-1's one real human trial actually supports its use for fine lines, or just for pigmentation.
Read it →A side-by-side look at Matrixyl and Pentapeptide-18 on evidence quality, cost, side effects, and which skin concern each one actually addresses.
Read it →A side-by-side on Matrixyl and Syn-Ake covering the evidence quality behind each, cost per bottle, side-effect load, and which skin concern each one actually fits.
Read it →A side-by-side look at GHK-Cu and Wolverine (BPC-157 plus TB-500) across evidence quality, cost, and side-effect load, so you know whether you need one or both.
Read it →A community post about massive shedding on GHK-Cu, broken down against what the peptide's hair mechanism actually predicts.
Read it →Why some people notice rough sleep in the first week or two of KLOW, what's actually driving it, and when it's worth a second look.
Read it →How to calculate Selank concentration correctly for a nasal spray, and why the diluent you pick matters as much as the math.
Read it →A look at what the human trial data actually shows for Decapeptide-12 on melasma, photodamage, and post-inflammatory hyperpigmentation, and where it fits against hydroquinone.
Read it →A look at what the Decapeptide-12 (Lumixyl) trials actually measured, and why the fine-lines claim rides on pigment data rather than wrinkle data.
Read it →A side-by-side look at TB-500 and GHK-Cu across evidence quality, cost, side effects and who each one actually fits, so you can pick based on your goal instead of the hype.
Read it →A practical checklist for telling real GHK-Cu from a fake or degraded vial, straight from a question a buyer posted after getting spooked by their own peptide.
Read it →A rundown of the documented Retatrutide side effects, their incidence rates from trial data, and the specific fixes for each one.
Read it →A practical look at SS-31 side effects, how often they show up in the human trial data, and what to actually do about each one.
Read it →A look at what SLU-PP-332's rodent data actually shows about energy and fatigue, and what it does not yet tell us about people.
Read it →A side-by-side look at enclomiphene and PT-141 across evidence quality, cost, side effects, and which guy or which situation each one actually fits.
Read it →HCG and PT-141 solve different problems on the sexual-health side, one preserves testicular function on TRT and the other treats low desire, so the comparison is about matching the tool to the actual gap.
Read it →Why TB-500 needs zinc, vitamin C, and collagen to finish the job it starts, and how much of each people actually use.
Read it →What to actually eat and supplement, electrolytes, protein, and fibre, to avoid the deficits Tesofensine's appetite suppression can quietly create.
Read it →What the kisspeptin trials actually measured, and how that lines up with the fertility claims vendors make.
Read it →How kisspeptin's human trials on libido and sexual desire actually hold up, and what a real dosing protocol looks like.
Read it →A look at what the Russian stroke and brain-injury record on Semax supports for post-concussion recovery, and where the evidence stops and extrapolation starts.
Read it →A plain look at what Syn-Ake and Nonapeptide-1 each actually do, what evidence backs them, and whether pairing them in one serum makes sense.
Read it →A side-by-side look at what Argireline and Nonapeptide-1 actually do, what evidence backs each one, and which one fits your actual skin goal.
Read it →A plain comparison of Argireline and Decapeptide-12 on evidence, cost, and who actually needs both in a topical stack.
Read it →A plain look at what MOTS-c side effects actually look like, from the common injection-site reaction to the rare drug-interaction risks worth flagging with your doctor.
Read it →A route-by-route look at whether Semax's anxiety relief holds up once you separate the nasal spray from the animal studies behind the anxiolytic claim.
Read it →Enclomiphene restarts your own testosterone production while triptorelin is an FDA-approved cancer drug built to shut it down, and this breaks down what each one does, the evidence behind it, and who it actually fits.
Read it →HCG keeps the testes producing testosterone on TRT, while oxytocin is an off-label tool for bonding and libido, and the two rarely solve the same problem.
Read it →A rundown of which semaglutide side effects are normal and temporary, and which ones mean call your doctor now.
Read it →Thymosin Alpha-1 won't rebuild tissue like BPC-157 or TB-500, but for immune-compromised, older, or diabetic patients it may clear the real bottleneck standing between a wound and closing.
Read it →A side-by-side look at kisspeptin and oxytocin covering evidence strength, cost and access, side effects, and who actually needs which one.
Read it →What the mouse data on SLU-PP-332 actually shows for endurance capacity, the mechanism behind it, and why it's not ready for a human protocol yet.
Read it →A straight, cost-and-evidence comparison of running TB-500 alone against the full Wolverine blend, so you buy the one your actual injury or goal calls for.
Read it →5-Amino-1MQ and Methylene Blue fix two different mitochondrial problems, and one hard SSRI rule decides which is even on the table for you.
Read it →A straight verdict on whether Humanin and ARA-290 or Methylene Blue fits your actual problem, backed by the human trial data and the one drug interaction that decides it for a lot of readers.
Read it →What genuinely matters (and what doesn't) in your first weeks on CJC-1295, straight from the human data and the real-world protocol.
Read it →How 5-Amino-1MQ's NNMT-blocking mechanism relates to fatigue and energy, what the animal data actually supports, and the real-world dosing protocol.
Read it →A straight, no-hype comparison of what triptorelin and oxytocin actually do, their evidence, and who each one is really for.
Read it →A first-timer's walkthrough for starting Selank nasal spray: how to work out your actual dose, how much to use in week one, and what to expect while you wait for it to build.
Read it →What the human, animal, and mechanism data on Pinealon actually says about endurance capacity, and where it realistically fits in a stack.
Read it →A straight look at whether Pinealon's brain-focused research says anything real about insulin sensitivity, and what to try instead if blood sugar is the actual goal.
Read it →An honest side-by-side of DSIP and L-THP across evidence, cost, side effects, and who each one actually fits.
Read it →A straight comparison of P21 and L-THP: evidence quality, cost, side-effect load, and who actually needs which one.
Read it →Why switching compounding pharmacies or formulations on low dose naltrexone almost never matters as much as people fear, and what actually varies between batches.
Read it →A straight look at whether sermorelin actually improves sleep quality, and what the human evidence does and doesn't show.
Read it →Why tirzepatide plateaus after a prednisone taper or a switch from Mounjaro to compounded vials, and how to sort out which one is actually stalling your results.
Read it →How long to run KPV before cycling off, and the one situation where running it straight through actually makes sense.
Read it →A straight rundown of what actually goes wrong on methylene blue, from harmless blue urine to the one drug interaction that is a genuine hard stop.
Read it →A straight comparison of Selank and P21, the evidence behind each, and why pairing them isn't the automatic move online stacks make it look like.
Read it →GHK-Cu injection site pain is common because of its copper and acidic formulation, and dilution plus proper technique clears up most of it.
Read it →What's really behind the focus crash people report while studying or testing on semaglutide, and the fixes that actually work.
Read it →What actually causes semaglutide dosing mistakes, and how to fix your titration before a mix-up turns into an accidental overdose.
Read it →What the animal, lab, and human evidence actually says about TB-500 for skin repair and wound closure, plus the real-world dosing people run.
Read it →A straight comparison of Selank's proven anxiety evidence against Dihexa's retracted mechanism paper, and why you probably only need one of the two.
Read it →What labs actually make sense to run on a BPC-157 protocol, why no official panel exists, and why the recent FDA news doesn't change your monitoring strategy.
Read it →What actually happens when you stack AOD-9604 with Retatrutide, Tesamorelin, or MOTS-c, and why AOD shouldn't be the compound carrying your results.
Read it →The real DSIP side effects from the human trials, the mixed safety data behind them, and what to actually do about each one.
Read it →Why Tirzepatide seems to ease anxiety and anger for some users, and the honest, non-drug ways to chase that same steadiness.
Read it →Why weight loss plateaus on semaglutide, how to tell a real stall from a fixable habit, and what actually gets the number moving again.
Read it →A straight look at whether TB-500's repair mechanisms genuinely apply to gut lining and IBD, and what the evidence actually supports versus what people are guessing.
Read it →A straight look at what's actually known about SLU-PP-332 side effects, why the mouse data looks good, and the three real risks worth taking seriously today.
Read it →A straight, evidence-first comparison of Pinealon and 5-Amino-1MQ across mechanism, human data, cost, side effects, and who each one actually fits.
Read it →A cost, evidence, and side-effect breakdown of sermorelin versus somatropin, and who actually needs which one.
Read it →Why tirzepatide fatigue happens and the fastest, evidence-backed ways to fix it, from electrolytes to titration pace.
Read it →A beginner's guide to picking subcutaneous injection sites for Semax and Selank, including whether the two peptides can share one syringe.
Read it →A rundown of sermorelin's real reported side effects, ranked by how common they actually are, with what to do about each one.
Read it →A straight look at the actual cagrilintide muscle-preservation evidence, what's animal-only, and the protein-and-training fix that decides your real outcome.
Read it →A straight rundown of tesofensine's actual reported side effects, how often they show up, and what to do about each one.
Read it →A straight rundown of Wolverine's (BPC-157 + TB-500) actual side effects, what's common, what's rare, and the nuanced cancer question worth understanding before you start.
Read it →Which peptide stack you actually need: KLOW's four-ingredient blend or Wolverine's simpler BPC-157 and TB-500 pair, compared honestly.
Read it →Why running standalone TB-500 alongside KLOW usually means paying for the same peptide twice, and how to pick the one that actually matches your recovery goal.
Read it →Why HGH and tesamorelin work through different mechanisms, and the safer sequence for switching between them when your IGF-1 comes back elevated.
Read it →A straight look at TB-500 side effects, what is genuinely mild, what is a real mechanism-based caution, and why the vial usually matters more than the peptide.
Read it →A head-to-head look at sermorelin versus GHRP-2, GHRP-6, and Hexarelin across evidence quality, cost, side effects, and who each one actually fits.
Read it →A straight breakdown of cagrilintide side effects by actual incidence, from the boring GI stuff to the one risk that quietly wrecks results.
Read it →What GLOW's safety data actually says: the real side effects, who should avoid it, and how to manage what comes up.
Read it →I compare cagrilintide and tesofensine head to head on mechanism, evidence, and supply chain, and tell you which one actually deserves a spot in your fridge.
Read it →A straight look at whether stacking GLOW on top of Wolverine is worth the extra vial, or just spending twice for a bump you could get one simpler way.
Read it →A straight answer on how long to run a KLOW cycle, and why week-four congestion probably isn't about the vial at all.
Read it →How to think about adding anything, including Retatrutide, on top of KLOW without wasting either peptide.
Read it →A straight look at whether Foundayo's oral GLP-1 protects your muscle on its own, or whether you're the one who has to do that part.
Read it →A grounded rundown of orforglipron side effects, straight from the trial data, and exactly what to do about each one.
Read it →A plain look at what's actually been reported with the four-peptide KLOW blend, what's still unproven, and how to manage each risk.
Read it →A straight comparison of LL-37 and the Wolverine stack across evidence, cost, side effects, and which one actually fits your problem.
Read it →An honest, evidence-based comparison of TB-500 and LL-37 across mechanism, human trial evidence, cost, and side effects, so you know which one actually fits your problem.
Read it →Why Melanotan can turn your skin dark fast, which Melanotan you're actually running, and when a sudden tan is worth a second look.
Read it →The real, science-backed order of operations for glowing up this winter, foundation habits first, then the GLOW peptide stack.
Read it →Why tirzepatide fatigue happens and the five foundational fixes, hydration, protein, creatine, iron, and sleep, that clear it up fast.
Read it →A straight, cost-and-evidence comparison of the GLOW and KLOW peptide blends and which one actually fits your situation.
Read it →Injection site stinging is one of the most common complaints in the peptide space — and one of the most misunderstood. The culprit is almost never the peptide itself. Here's what's actually causing it and exactly how to fix it.
Read it →Ozempic patients were reporting better joints. Doctors called it the weight loss. Then a controlled experiment gave a second group of mice the exact same weight loss without the drug — and their cartilage kept breaking down anyway. Here's the mechanism nobody saw coming, and what it means if you're running any GLP-1 agonist.
Read it →CJC-1295 (with-DAC vs no-DAC), ipamorelin, and tesamorelin all raise growth hormone and IGF-1 through the pituitary — the differences between them are about pulse pattern, duration, and specific goals, NOT about one being safe while another is dangerous. Here's the honest trade-off matrix, why the widely-repeated 'CJC/Ipa is safer than Tesa because of sustained IGF-1' argument is wrong on the pharmacology, and what to actually think about when you're already on retatrutide or a low-dose GLP-1.
Read it →A 2026 Stanford PNAS paper identified the exact molecular reason GLP-1 drugs impair muscle regeneration — an enzyme called 15-PGDH that destroys the signaling molecule muscle stem cells need to activate. The drug that blocks it, MF-300, is in Phase 2 trials. Here's the full science and what it means for anyone on Ozempic, Mounjaro, or Retatrutide.
Read it →The mainstream story about arterial plaque — too much cholesterol, take a statin — misses the actual mechanism by a wide margin. Here's the real biology of atherosclerosis, why conventional treatments address the wrong problem, and five peptides that work on the root causes directly.
Read it →Most people only talk about the scale. But peer-reviewed trials show retatrutide cleared fatty liver in 93% of patients, cut knee pain by 75%, dropped the most dangerous blood fats by up to 40%, and may be protecting kidneys. Here's the full picture.
Read it →No documented kidney failure has been reported for any of the commonly stacked research peptides — MOTS-c, SS-31, retatrutide, CJC-1295/Ipamorelin, KPV, or BPC-157. Here's the compound-by-compound safety record, and the one documented renal signal (a different compound) worth understanding honestly.
Read it →The '20-50% loss per freeze-thaw cycle' claim you've read online isn't supported by the actual HPLC data. Here's what freeze-thaw cycling really does to a reconstituted peptide, why it's sequence-dependent, and the simple default that avoids the question entirely.
Read it →If your testosterone is low, you have two paths: replace it from outside, or restart your own production from inside. Four different levers — Enclomiphene, HCG, Gonadorelin, and Kisspeptin — restart the system at four different points, and your bloodwork tells you which one matches your specific breakdown.
Read it →A meaningful number of reasonable, non-pharma-funded doctors actively recommend against off-label peptide use. Here's their strongest argument, stated fairly, and exactly where I agree and where I don't.
Read it →The honest, credible skeptical case on BPC-157 — from named scientists and the American Peptide Society, not internet hype — and how to weigh it against the animal-data and real-world safety record. Read this before you hit the skeptical coverage on a random Google search.
Read it →For years this category was one molecule and one receptor. By 2026 it's fourteen drugs across four receptors. Here's the full map — what each one does, what's actually beaten Tirzepatide (nothing yet), and how to think about starting now versus waiting.
Read it →MOTS-c or NAD+? CoQ10 or SS-31? The mitochondrial supplement aisle is confusing because these tools target completely different parts of the machine. Here's the 5-part anatomy map that makes sense of all of it.
Read it →Raising your GH-secretagogue dose doesn't always raise your IGF-1 — sometimes it does the opposite. Here's the liver conversion mechanism and the three signals that actually control the output.
Read it →Most peptide content treats 'FDA-approved' and 'research chemical' as the only two options. There's a real middle pathway — the compounding pharmacy — governed by an FDA list most people have never heard of. Here's how it actually works, and why BPC-157 still isn't on it.
Read it →If you're on Zoloft, Lexapro, or Prozac and thinking about peptides, here's the honest answer: almost everything is fine. A short list isn't. I'll show you exactly which is which, and why the real risk usually isn't the peptide at all.
Read it →Prednisone works, but it's a broad, costly tool. Here's what's actually known about layering peptides on top of it — what's genuinely complementary, what needs your prescriber in the loop, and what peptides do for autoimmune inflammation in the first place.
Read it →Losing weight fast — on Retatrutide, semaglutide, tirzepatide, or just aggressive dieting — can push your homocysteine up and shift your PSA. Both are predictable, explainable, and fixable. Here's the lab-monitoring companion piece nobody writes.
Read it →Not every 'third-party tested' claim points to a real lab. Here's a straight look at the six labs that actually do meaningful peptide testing, what each one is good for, and how to verify a COA yourself.
Read it →Most 'Made in USA' research-peptide labels are stretching the truth. Here's the honest global manufacturing picture — the handful of real US facilities, the Chinese supply chain everyone depends on, and what actually protects you instead of a country-of-origin claim.
Read it →A refillable auto-injector pen swaps your daily draw-and-inject ritual for dial, click, done — here's what one actually is, what to buy, and how to set it up.
Read it →A Certificate of Analysis is the one document that tells you whether your vial actually contains what the label says. Here's what a real one looks like, the verification trick almost nobody knows, and how to catch a fake in under two minutes.
Read it →Mixing two peptides in one syringe is usually fine if you inject within about 30 seconds of drawing both — here's the immediate injection protocol, which combos are genuinely safe, and which ones need their own syringe.
Read it →Most fat-loss peptide protocols pull one lever and stall. The stronger approach layers four different mechanisms — appetite/metabolism, mitochondrial biogenesis, mitochondrial repair, and the growth-hormone axis — sequenced over 12 weeks instead of piled on at once.
Read it →No peptide has been proven to reverse human aging — but some peptides may genuinely improve the systems that decline with age: skin, recovery, sleep, body composition, inflammation. Here's the honest framework for telling the difference between feeling younger and being younger.
Read it →KPV is a tiny three-amino-acid peptide that does one thing very precisely — blocks the master inflammation switch inside cells. An honest walk through what KPV is, what the evidence actually shows for allergies, where it fits, where it doesn't, and how to think about trying it.
Read it →Can the same peptides that humans use safely be used on dogs and cats? An honest look at the cross-species evidence, the compounds with the strongest track record, the cat-specific safety calls that genuinely matter, and how to think about it with your vet.
Read it →Do Ozempic, Mounjaro, and Retatrutide eat your heart, esophagus, or vital organs? The honest, study-backed answer about which muscles actually disappear on the GLP-1 receptor agonist class — and the four-part playbook for keeping the muscle you want.
Read it →A calm, step-by-step walkthrough of the subcutaneous peptide injection — the supplies, the technique, where on your body to do it, and how to rotate sites so it works every time.
Read it →The one-minute answer is bacteriostatic water — here's what it is, why the tiny bit of benzyl alcohol matters for a vial you'll use over weeks, and the rare cases where plain sterile water is the right call.
Read it →Reconstitution is just turning freeze-dried powder into an injectable liquid by adding bacteriostatic water. Here's the whole process — add slowly, swirl don't shake, refrigerate — plus the one piece of math that sets your dosing.
Read it →The single cleanest way to understand peptides: steroids FLOOD your body with the finished hormone and shut your own production off, while peptides SIGNAL your body to make more of its own — explained through growth-hormone peptides and testosterone.
Read it →A balanced, honest look at peptide safety: why the signaling-molecule mechanism makes them safer than feared, which peptides have strong track records, where the real risks live, and the prescription-drug double standard.
Read it →The honest foundation: what a peptide actually is, the lock-and-key mechanism, and why peptides work — explained through GLP-1, retatrutide, BPC-157 and TB-500.
Read it →Nothing here matches that search.
More articles are on the way. In the meantime: search every peptide · reconstitution & dosing calculator · build a protocol · ask Pep